本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Soleno Therapeutics

52.57
0.0000
盤後52.570.00000.00%18:58 EDT
成交量:415.46萬
成交額:2.19億
市值:27.14億
市盈率:134.79
高:52.68
開:52.57
低:52.53
收:52.57
52周最高:90.32
52周最低:29.43
股本:5,162.44萬
流通股本:4,487.09萬
量比:0.92
換手率:9.26%
股息:- -
股息率:- -
每股收益(TTM):0.3900
每股收益(LYR):0.3900
淨資產收益率:6.01%
總資產收益率:2.09%
市淨率:6.03
市盈率(LYR):134.79

資料載入中...

2024/01/06

重要事件披露

Form 8-K - Current report
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/28

SEC問詢函

Form CORRESP - Correspondence
2023/10/23

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/16

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/11

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/10

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/06

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/04

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/29

重要事件披露

Form 8-K - Current report
2023/09/29

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/28

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses